SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SINGAPORE, Dec. 16, 2025 /PRNewswire/ -- Sharpa, a Singapore-headquartered AI robotics firm, has achieved a major milestone with the launch of mass production for...
BEIJING, Dec. 16, 2025 /PRNewswire/ -- Despite economic headwinds, over 60% of Chinese onshore listed companies intend to maintain or raise their input in decarbonization,...